Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1202 | U 50488 hydrochloride | Kappa-opioid agonist | €65.00 | |
| 1412 | SNC 80 | δ-opioid agonist | €95.00 | |
| 1413 | SB 612111 hydrochloride | NOP antagonist | €70.00 | |
| 2416 | Naltrexone hydrochloride | Competitive opioid antagonist with preference for µ- and κ-receptors | €45.00 | |
| 2415 | Naloxone hydrochloride | Neutral opioid antagonist | €45.00 | |
| 1230 | Naloxone Benzoylhydrazone | Kappa-opioid agonist | €85.00 | |
| 1205 | Naloxonazine dihydrochloride | Opioid antagonist | €75.00 | |
| 1573 | Nalmefene hydrochloride | Opioid antagonist | €80.00 | |
| 1577 | Nalbuphine hydrochloride | Analgesic. Κ-opioid agonist and μ-opioid antagonist/partial agonist | €110.00 | |
| 1805 | JTC 801 | NOP receptor antagonist | €85.00 | |
| 2781 | HS666 hydrochloride | Kappa-opioid partial agonist | €135.00 | |
| 1226 | GNTI dihydrochloride | Kappa-opioid antagonist | €125.00 | |
| 1213 | Funaltrexamine hydrochloride, β- | Mu-opioid antagonist | €90.00 | |
| 1140 | Fedotozine tartrate | Kappa(1a) opioid agonist | €135.00 | |
| 1163 | Binaltorphimine dihydrochloride, nor- | Kappa-opioid antagonist | Inquire | |